aCCI-SOFA模型用于预测ICU脓毒症3患者住院死亡率的开发与内外部验证:多中心回顾性队列研究
本研究通过logistic回归调整前3天最大SOFA评分(Max Day3 SOFA)与住院死亡率的关系,并将年龄校正Charlson共病指数(aCCI)作为连续变量纳入,构建aCCI-SOFA模型。研究使用MIMIC-IV、MIMIC-III(CareVue)和FAHWMU队列的脓毒症3患者进行开发、内部验证和外部验证,结局为住院死亡率。与Max Day3 SOFA相比,aCCI-SOFA模型在所有队列中受试者工作特征曲线下面积均显著提高:开发队列0.81 vs 0.75(P<0.001)、内部验证队列0.81 vs 0.76(P<0.001)、MIMIC-III(CareVue)队列0.75 vs 0.68(P<0.001)、FAHWMU队列0.72 vs 0.67(P=0.001)。敏感性分析提示,aCCI-SOFA在早期非脓毒性休克患者中应用临床价值更大,与原始SOFA评分在所有队列中差异均有统计学意义(P<0.05)。
要点
- aCCI-SOFA模型将年龄校正Charlson共病指数(aCCI)作为连续变量与第3天最大SOFA评分结合,用于预测ICU脓毒症3患者住院死亡率。
- 在开发队列中,aCCI-SOFA的AUC为0.81,优于Max Day3 SOFA的0.75(P<0.001)。
- 在MIMIC-III(CareVue)外部验证队列中,aCCI-SOFA的AUC为0.75,优于Max Day3 SOFA的0.68(P<0.001)。
- 在FAHWMU外部验证队列中,aCCI-SOFA的AUC为0.72,优于Max Day3 SOFA的0.67(P=0.001)。
- 敏感性分析提示,aCCI-SOFA在早期非脓毒性休克患者中临床价值更大,与原始SOFA评分在所有队列中差异有统计学意义(P<0.05)。
适用人群与场景
- ICU的脓毒症3患者,来自MIMIC-IV、MIMIC-III(CareVue)和FAHWMU队列。
- 敏感性分析针对早期非脓毒性休克患者。
研究设计与关键结果
- 研究类型:多中心回顾性队列研究;使用MIMIC-IV、MIMIC-III(CareVue)和FAHWMU队列的脓毒症3患者进行模型开发、内部验证和外部验证。
- 模型构建:通过logistic回归调整前3天最大SOFA评分(Max Day3 SOFA)与住院死亡率的关系,并将年龄校正Charlson共病指数(aCCI)作为连续变量纳入,构建aCCI-SOFA模型。
- 主要结局:住院死亡率。
- 预测性能评估:使用受试者工作特征曲线下面积评估区分度,校准曲线评估校准度,Brier评分评估整体预测效果。
- 与Max Day3 SOFA相比,aCCI-SOFA模型AUC在开发队列为0.81 vs 0.75(P<0.001),内部验证队列为0.81 vs 0.76(P<0.001),MIMIC-III(CareVue)队列为0.75 vs 0.68(P<0.001),FAHWMU队列为0.72 vs 0.67(P=0.001)。
- 敏感性分析提示,aCCI-SOFA在早期非脓毒性休克患者中应用临床价值更大,与原始SOFA评分在所有队列中差异有统计学意义(P<0.05)。
证据类型、等级与局限
- 证据类型:多中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于ICU脓毒症3患者,aCCI-SOFA模型可能改善住院死亡风险的预测,优于单独使用第3天最大SOFA评分。
- 作者认为,aCCI-SOFA在早期非脓毒性休克患者中应用临床价值更大。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Objective: To achieve a better prediction of in-hospital mortality, the Sequential Organ Failure Assessment (SOFA) score needs to be adjusted and combined with comorbidities. This study aims to enhance the prediction of SOFA score for in-hospital mortality in patients with Sepsis-3. Methods: This study adjusted the maximum SOFA score within the first 3 days (Max Day3 SOFA) in relation to in-hospital mortality using logistic regression and incorporated the age-adjusted Charlson Comorbidity Index (aCCI) as a continuous variable to build the age-adjusted Charlson Comorbidity Index-Sequential Organ Failure Assessment (aCCI-SOFA) model. The outcome was in-hospital mortality. We developed, internally validated, and externally validated the aCCI-SOFA model using cohorts of Sepsis-3 patients from the MIMIC-IV, MIMIC-III (CareVue), and the FAHWMU cohort. The predictive performance of the model was assessed through discrimination and calibration, which was assessed using the area under the receiver operating characteristic and calibration curves, respectively. The overall predictive effect was evaluated using the Brier score. Measurements and main results: Compared with the Max Day3 SOFA, the aCCI-SOFA model showed significant improvement in area under the receiver operating characteristic with all cohorts: development cohort (0.81 vs 0.75, P < 0.001), internal validation cohort (0.81 vs 0.76, P < 0.001), MIMIC-III (CareVue) cohort (0.75 vs 0.68, P < 0.001), and FAHWMU cohort (0.72 vs 0.67, P = 0.001). In sensitivity analysis, it was suggested that the application of aCCI-SOFA in early nonseptic shock patients had greater clinical value, with significant differences compared with the original SOFA scores in all cohorts ( P < 0.05). Conclusion: For septic patients in intensive care unit, the aCCI-SOFA model exhibited superior predictive performance. The application of aCCI-SOFA in early nonseptic shock patients had greater clinical value.
参考来源
- Huang Y, Gao Y, Quan S, et al. DEVELOPMENT AND INTERNAL-EXTERNAL VALIDATION OF THE ACCI-SOFA MODEL FOR PREDICTING IN-HOSPITAL MORTALITY OF PATIENTS WITH SEPSIS-3 IN THE ICU: A MULTICENTER RETROSPECTIVE COHORT STUDY. Shock. 2024. PMID: 38407987. doi:10.1097/SHK.0000000000002311
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。